Anders Grubb
151 – 160 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Lack of the Cysteine-Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
- Contribution to journal › Article
-
Mark
Cystatin C as a marker of GFR - history, indications, and future research
- Contribution to journal › Scientific review
-
Mark
Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse
- Contribution to journal › Article
-
Mark
In search of selective inhibitors of cysteine protease, cathepsin K
- Contribution to journal › Article
-
Mark
Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E-Null Mice.
- Contribution to journal › Article
-
Mark
A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula.
- Contribution to journal › Article
-
Mark
3D domain-swapped human cystatin c with amyloidlike intermolecular beta-sheets
- Contribution to journal › Article
-
Mark
Novel azapeptide inhibitors of cathepsins B and K. Structural background to increased specificity for cathepsin B
- Contribution to journal › Article
-
Mark
Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
- Contribution to journal › Article
-
Mark
Different cysteine proteinases involved in bone resorption and osteoclast formation
- Contribution to journal › Article
